Elixinol Wellness Income Statement

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15.5	14.96	8.27	7.06	9.34
Revenue Growth (YoY)	3.64%	80.87%	17.21%	-24.45%	-37.79%
Cost of Revenue	9.79	9.6	5	4.07	7.22
Gross Profit	5.71	5.36	3.27	2.99	2.12
Selling, General & Admin	9.39	8.78	8.58	12.28	18.82
Other Operating Expenses	0.08	0.54	-0.54	-0.51	-0.5
Operating Expenses	10.77	10.41	9.31	12.74	20
Operating Income	-5.06	-5.05	-6.04	-9.75	-17.89
Interest Expense	-0.49	-0.21	-0.1	-0.07	-0.09
Interest & Investment Income	0.01	0.03	0.21	0.02	0.05
Currency Exchange Gain (Loss)	-0.23	0.01	-0.01	-0.04	0.08
Other Non Operating Income (Expenses)	-	-	-	-	-0.33
EBT Excluding Unusual Items	-5.77	-5.22	-5.94	-9.84	-18.18
Gain (Loss) on Sale of Investments	-	-	-1.33	-	-
Gain (Loss) on Sale of Assets	0	-0	-0	0.03	-0.08
Asset Writedown	-0.27	-0.09	-0.24	-0.77	-0.75
Other Unusual Items	-	-	-	0.01	1.92
Pretax Income	-6.04	-5.31	-7.5	-10.57	-17.09
Income Tax Expense	-0.54	-3.59	0	0	-0.07
Earnings From Continuing Operations	-5.5	-1.72	-7.51	-10.57	-17.03
Net Income to Company	-5.5	-1.72	-7.51	-10.57	-17.03
Net Income	-5.5	-1.72	-7.51	-10.57	-17.03
Net Income to Common	-5.5	-1.72	-7.51	-10.57	-17.03
Shares Outstanding (Basic)	256	155	59	40	39
Shares Outstanding (Diluted)	256	155	59	40	39
Shares Change (YoY)	65.77%	160.95%	49.90%	0.40%	75.46%
EPS (Basic)	-0.02	-0.01	-0.13	-0.27	-0.43
EPS (Diluted)	-0.02	-0.01	-0.13	-0.27	-0.43
Free Cash Flow	-3.28	-3.53	-2.77	-8.16	-14.23
Free Cash Flow Per Share	-0.01	-0.02	-0.05	-0.21	-0.36
Gross Margin	36.86%	35.82%	39.50%	42.31%	22.68%
Operating Margin	-32.63%	-33.78%	-73.09%	-138.20%	-191.54%
Profit Margin	-35.48%	-11.51%	-90.79%	-149.84%	-182.32%
Free Cash Flow Margin	-21.15%	-23.60%	-33.50%	-115.62%	-152.40%
EBITDA	-4.41	-4.51	-5.92	-9.57	-17.4
EBITDA Margin	-28.43%	-30.17%	-71.60%	-135.69%	-186.33%
D&A For EBITDA	0.65	0.54	0.12	0.18	0.49
EBIT	-5.06	-5.05	-6.04	-9.75	-17.89
EBIT Margin	-32.63%	-33.78%	-73.09%	-138.20%	-191.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.